Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Cellebrite CLBT Stock Holding History

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,454,908	Closed	-$20M	–	77
2026 Q1	$20M	Buy	1,454,908 +373,830	+35%	+$5.63M	1.31%	24
2025 Q4	$19.5M	Hold	1,081,078	–	–	1.27%	24
2025 Q3	$20M	Hold	1,081,078	–	–	1.35%	24
2025 Q2	$17.3M	Sell	1,081,078 -18,637	-2%	-$332K	1.25%	27
2025 Q1	$21.4M	Buy	1,099,715 +83,687	+8%	+$1.76M	1.75%	18
2024 Q4	$22.4M	Sell	1,016,028 -520,915	-34%	-$10M	1.76%	18
2024 Q3	$25.9M	Buy	1,536,943 +471,494	+44%	+$7M	2.15%	13
2024 Q2	$12.7M	Sell	1,065,449 -160,076	-13%	-$1.79M	1.15%	27
2024 Q1	$13.6M	Buy	1,225,525 +1,020,504	+498%	+$10.4M	1.18%	28
2023 Q4	$1.77M	Buy	+205,021	New	+$1.59M	0.12%	75

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Central Securities New York $1.34B AUM 21.03% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's CLBT Position: Q2 2026 in Review

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 1,454,908 shares — an estimated $20M sold.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in CLBT in Q4 2023 and held it in 10 quarters. The position peaked at $25.9M in Q3 2024. 101 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold 1,454,908 Cellebrite shares in Q2 2026, an estimated $20M.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in Cellebrite in Q4 2023 and held it in 10 quarters.
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's Cellebrite position peaked at $25.9M in Q3 2024.
101 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's 13F filing for Q2 2026, filed 5 Aug 2026.